Review Article
A Systematic Review of Ethanol and Fomepizole Use in Toxic Alcohol Ingestions
Table 2
Patient demographics; aggregate data.
|
Data | Variable | Age (years) (mean ± SD) | Gender (% male) | Time to diagnosis (hours) (mean ± SD) | Toxic alcohol level (mmol/L) (mean ± SD) | Ethanol Level (mmol/L) (mean ± SD) | pH (mean ± SD) |
| Ethylene Glycol | | | | | | | Fomepizole | | | | | | | Cases (n = 31) | 42.5 ± 14.7 | 67% | 8.8 ± 7.2 | 46.2 ± 58.9 | 8.2 ± 13.6 | 7.16 ± 0.21 | Brent 1999 (n = 19) | 41 ± 13 | 89% | 6.6–20.8 | 3.87–71.85 | 0–39.3 | 6.93–7.47 | Megarbane 2008 (n = 15) | 31 (27–51) | 83% | | PO: 1.0 ± 11.3 IV: 6.8 ± 53.5 | | | Ethanol | | | | | | | Cases (n = 166) | 42.2 ± 14.3 | 84% | 5.3 ± 8.4 | 24.7 ± 43.9 | 20.3 ± 31.1 | 7.21 ± 0.22 | Karlson-Stiber 1992 (n = 32) | 20–69 | | | | | 6.7–7.4 | Hylander 1996 (n = 17) | 38 ± 15 | 94% | | Alive: 33 ± 38.6 Dead: 8.7 ± 6.1 | | Alive: 7.2 ± 0.1 Dead: 6.9 ± 0.2 | Both | | | | | | | Cases (n = 15) | 40.6 ± 15.4 | 80% | 13.3 ± 12.6 | 20.3 ± 16.8 | 0 | 7.18 ± 0.16 |
| Methanol | | | | | | | Fomepizole | | | | | | | Cases (n = 72) | 44.9 ± 12.8 | 68% | 13.0 ± 10.7 | 43.8 ± 48.3 | 7.3 ± 18.6 | 7.16 ± 0.27 | Megarbane 2008 (n = 9) | 46 (38–55) | 83% | | PO: 3.12 IV: 7.49 ± 32.45 | | | Ethanol | | | | | | | Cases (n = 201) | 39.0 ± 13.7 | 73% | 15.2 ± 17.2 | 63.0 ± 61.4 | 6.3 ± 12.3 | 7.13 ± 0.25 | Krishnamurthi 1968 (n = 89) | | 87% | | | | | Paasma 2007 (n = 111) | | | | Alive: 1.3–175 Dead: 28.4–194.7 | | Alive: 7.14 Dead: 6.78 | Moghadami 2008 (n = 62) | 31 ± 12.7 | 100% | | 8.49 ± 9.69 | 5.10 ± 6.10 | | Taheri 2010 (n = 42) | 38 (15–81) | 93% | 48.6 (24–72) | 9.39 (6.86–20.9) | | 6.9 (6.3–7.2) | Cases (n = 18) | 43.7 ± 17.2 | 56% | 11.5 ± 13.9 | 58.3 ± 68.2 | 4.4 ± 10.5 | 7.26 ± 0.14 | Both | | | | | | | Cases (n = 18) | 43.7 ± 17.2 | 56% | 11.5 ± 13.9 | 58.3 ± 68.2 | 4.4 ± 10.5 | 7.26 ± 0.14 |
|
|